Filing Details
- Accession Number:
- 0001543077-15-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-21 09:27:37
- Reporting Period:
- 2015-08-19
- Filing Date:
- 2015-08-21
- Accepted Time:
- 2015-08-21 09:27:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1105533 | Argos Therapeutics Inc | ARGS | Pharmaceutical Preparations (2834) | 562110007 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1543077 | D Jeffrey Abbey | Argos Therapeutics, Inc. 4233 Technology Drive Durham NC 27704 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-08-19 | 5,500 | $4.75 | 5,500 | No | 4 | P | Indirect | By IRA |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By IRA |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $4.65 to $4.8195; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the Registrant, or a security holder of the Registrant.